-
1
Laboratory medicine in the era of precision medicine – dream or reality?
Published 2019-04-01Get full text
Article -
2
-
3
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
Published 2020-01-01“…We describe the rationale and design of the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, an innovative multidisciplinary alternative to traditional drug discovery. …”
Get full text
Article -
4
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
Published 2017-03-01Get full text
Article -
5
The role of inhaled methoxyflurane in acute pain management
Published 2018-10-01“…Keith M Porter,1 Anthony D Dayan,2 Sara Dickerson,3 Paul M Middleton4,5 1Trauma Department, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK; 2Independent Consultant, London, UK; 3Medical Affairs, Mundipharma International Limited, Cambridge, UK; 4Emergency Medicine Research Unit, Liverpool Hospital, Sydney, NSW, Australia; 5Distributed Research in Emergency and Acute Medicine (DREAM) Collaboration, Sydney, NSW, Australia Abstract: Methoxyflurane is an inhaled analgesic administered via a disposable inhaler which has been used in Australia for over 40 years for the management of pain associated with trauma and for medical procedures in children and adults. …”
Get full text
Article -
6
Cost-effectiveness strategies in OSAS management: a short review
Published 2017-12-01Get full text
Article -
7
-
8
Development and maintenance of a medical education research registry
Published 2020-06-01“…Grossman School of Medicine established the Database for Research on Academic Medicine (DREAM). DREAM is a database of routinely collected, de-identified undergraduate (UME, medical school leading up to the Medical Doctor degree) and graduate medical education (GME, residency also known as post graduate education leading to eligibility for specialty board certification) outcomes data available, through application, to researchers. …”
Get full text
Article -
9
Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias?
Published 2022“…This scientific commentary refers to ‘No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study’ by Desai et al. (https://doi.org/10.1093/braincomms/fcac247) in Brain Communications.…”
Journal article